Assessing the risk of inhibitor formation with different factor VIII products.
Mannucci
Pier M
PM
D015331:Cohort Studies; D005169:Factor VIII / Q000009:adverse effects* / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000302:isolation & purification; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000276:immunology
D011994:Recombinant Proteins; D005169:Factor VIII